{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"May 21, 2021 This Week in Cardiology Podcast","description":"John Mandrola, MD, presents an ACC 2021 recap. https:\/\/www.medscape.com\/twic ACC 2021 Reveiw I -- Left Atrial Appendage Closure LAAOS III: Surgical LAA Closure Cuts AF Stroke Risk by One Third https:\/\/www.medscape.com\/viewarticle\/951232 - Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2101897 Watchman Registry: 1-Year Stroke Estimates Reassuringly Low https:\/\/www.medscape.com\/viewarticle\/951235 II - Angiotensin-Neprilysin Inhibition PARADISE-MI: Sacubitril\/Valsartan Can't Beat Ramipril in Patients With Acute MI https:\/\/www.medscape.com\/viewarticle\/951236 Life Trial Rationale Paper: https:\/\/doi.org\/10.1016\/j.jchf.2020.05.005 III - Renal Denervation Ultrasound Renal Denervation Drops BP in Patients on Triple Therapy https:\/\/www.medscape.com\/viewarticle\/951248 IV -- Clopidogrel vs ASA post Stent HOST-EXAM: Clopidogrel Beats Aspirin as Monotherapy After Stenting https:\/\/www.medscape.com\/viewarticle\/951294 - Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial https:\/\/doi.org\/10.1016\/S0140-6736(21)01063-1 V -- AF Ablation in HF RAFT-AF, Despite Itself, Hints at Advantage for Ablation Rhythm Control in Heart Failure With AF. https:\/\/www.medscape.com\/viewarticle\/951326 VI -- Rivaroxaban in COVID-19 \u2013 ACTION Trial Therapeutic Rivaroxaban Dose: Risk Outweighs Benefit in Stable COVID https:\/\/www.medscape.com\/viewarticle\/951475 VII -- REHAB-HF Trial Novel Rehab Program Fights Frailty, Boosts Capacity in Advanced HF https:\/\/www.medscape.com\/viewarticle\/951244 - Physical Rehabilitation for Older Patients Hospitalized for Heart Failure https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2026141 VIII \u2013 ASA 81 vs 325 \u2013 ADAPTABLE Trial ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD? https:\/\/www.medscape.com\/viewarticle\/951230 - Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2102137 Perspectives: Eight Things to Know About the Surgical Left Atrial Appendage Occlusion (LAAOS III) Trial https:\/\/www.medscape.com\/viewarticle\/951229 PARADISE-MI Makes Me Question the Benefits of Sacubitril\/Valsartan https:\/\/www.medscape.com\/viewarticle\/951239 Sacubitril\/Valsartan: Trending Toward PARADISE Post MI https:\/\/www.medscape.com\/viewarticle\/950300 Renal Denervation for Resistant Hypertension Is Not Back on Track https:\/\/www.medscape.com\/viewarticle\/951497 Acute Alcohol Consumption Raises Risk for Atrial Fibrillation https:\/\/www.medscape.com\/viewarticle\/950938 Does ADAPTABLE Inform Aspirin Dosing for Secondary Prevention? https:\/\/www.medscape.com\/viewarticle\/950969 You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https:\/\/www.medscape.com\/features\/public\/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https:\/\/www.medscape.com\/author\/bob-harrington Questions or feedback, please contact news@medscape.net ","author_name":"This Week in Cardiology","author_url":"https:\/\/www.medscape.com\/index\/list_10295_0","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/19193447\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/19193447"}